Attention Deficit Hyperactivity Disorder
NCT06232226, Not applicable, Recruiting, Nantes University Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Attention Deficit Hyperactivity Disorder | ClinicalTrials.gov |
| NCT number | NCT06232226 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 80 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Nantes University Hospital | ClinicalTrials.gov |
| Conditions | Attention Deficit Hyperactivity Disorder, Behavior Hyperactive, Behavior Disorders | ClinicalTrials.gov |
| Interventions | Patients suffering from the co-occurrence of ADHD and addiction(s) | ClinicalTrials.gov |
| First posted | 2024-01-30 | ClinicalTrials.gov |
| Last updated | 2026-04-17 | ClinicalTrials.gov |
Registered outcomes 22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Functional impairment | Inclusion and 12-month follow-up | Weiss Functional Impairment Rating Scale (WFIRS-S) (scores of the 7 domains and total score) | ClinicalTrials.gov |
| Secondary | Type and severity of ADHD | Inclusion | Diagnostiscal Interview Voor Attention deficit hyperactivity disorder (DIVA-5) | ClinicalTrials.gov |
| Secondary | Symptoms of ADHD | Inclusion and 12-month follow-up | Adult ADHD Self-Report Scale Symptom Checklist (ASRS-1.1) (inattention and hyperactivity/impulsivity scores) | ClinicalTrials.gov |
| Secondary | Addictive disorders - substance use disorders (including tobacco, alcohol and other substances) | Inclusion and 12-month follow-up | Mini International Neuropsychiatric Interview- Simplified for Diagnostic and Statistical Manual (DSM)-5 (MINI-S) | ClinicalTrials.gov |
| Secondary | Addictive disorders - gambling disorder | Inclusion and 12-month follow-up | National Opinion research center DSM Screen for gambling problems (NODS) | ClinicalTrials.gov |
| Secondary | Addictive disorders - sex addiction | Inclusion and 12-month follow-up | Structured interview adapted from the NODS to explore the diagnostic criteria proposed by Carnes et al in 2012 | ClinicalTrials.gov |
| Secondary | Addictive disorders - gambling disorder | Inclusion and 12-month follow-up | Structured interview adapted from the NODS to explore the diagnostic criteria proposed in the third section of the DSM-5 for the Internet gaming disorder | ClinicalTrials.gov |
| Secondary | Addictive disorders - eating addiction | Inclusion and 12-month follow-up | Yale Food Addiction Scale (YFAS 2.0) | ClinicalTrials.gov |
| Secondary | Psychiatric disorders | Inclusion and 12-month follow-up | MINI-S | ClinicalTrials.gov |
| Secondary | Neuropsychological profile - selective attention | Inclusion and 12-month follow-up | D2-R test (CCT standard score, E% standard score and CC standard score) | ClinicalTrials.gov |
| Secondary | Neuropsychological profile - short-term and working memory | Inclusion and 12-month follow-up | Digit memory test (standardized scores of numbers of items correctly recalled (direct order, indirect order, ascending order, total), span sizes (direct order, indirect order, ascending order)) | ClinicalTrials.gov |
| Secondary | Neuropsychological profile - inhibition | Inclusion and 12-month follow-up | Stroop test (standardized execution times (naming condition, interference condition), standardized numbers of uncorrected errors (naming condition, interference condition), and standardized interference score) | ClinicalTrials.gov |
| Secondary | Neuropsychological profile - spontaneous flexibility | Inclusion and 12-month follow-up | Verbal fluency test (standardized scores for the number of words cited and the number of errors, in both conditions (literal and categorical)) | ClinicalTrials.gov |
| Secondary | Neuropsychological profile - planning | Inclusion and 12-month follow-up | Zoo test (total profile score) | ClinicalTrials.gov |
| Secondary | Psychopathological profile - impulsivity | Inclusion and 12-month follow-up | Urgency, Premeditation (lack of), Perseverance (lack of), Sensation seeking impulsivity behavior scale (UPPS-P) (5 scores) | ClinicalTrials.gov |
| Secondary | Psychopathological profile - emotional dysregulation | Inclusion and 12-month follow-up | Difficulties in Emotion Regulation Scale (DERS-16) (5 scores and total score) | ClinicalTrials.gov |
| Secondary | Psychopathological profile - sensorial profile | Inclusion and 12-month follow-up | Sensory profile of Winnie Dunn - adult version (category and raw scores in the 4 quadrants) | ClinicalTrials.gov |
| Secondary | Psychopathological profile - self-esteem | Inclusion and 12-month follow-up | Rosenberg Self-Esteem Scale (RSES) (total score) | ClinicalTrials.gov |
| Secondary | Quality of life survey | Inclusion and 12-month follow-up | World Health Organization Quality Of Life (WHOQoL-26) (4 scores) | ClinicalTrials.gov |
| Secondary | Care received | 12-month follow-up | Effective implementation of treatment with MPH (yes/no) or atomoxetine (yes/no), If no, reasons for not implementing it (for MPH), Care provided (Cognitive remediation / behavioral and cognitive therapy / psychoeducation / other psychosocial intervention (details) / other drug treatment), Reported compliance and misuse for MPH and atomoxetine, Reported compliance for non-drug care, Tolerance: numerical scale from 0 to 10 for the evaluation of the main adverse effects (for MPH and for atomoxetine). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)